ConductScience.org, home

Comparison · NCT01477320-bf0b63c4

Pantoprazole 40mg IV Daily and Tube Feed vs Placebo and Tube Feed.: Number of Subjects With ICU-acquired C. Difficile Pseudomembranous Colitis.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Pantoprazole 40mg IV Daily and Tube Feed vs Placebo and Tube Feed.: Number of Subjects With ICU-acquired C. Difficile Pseudomembranous Colitis. Trial comparisons, record NCT01477320-bf0b63c4. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01477320-bf0b63c4

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01820.003220.0961wilson
Risk in group 20.06380.02190.172wilson
Risk difference, group 1 minus group 2-0.0456-0.1540.0428newcombe hybrid score
Risk ratio, group 1 over group 20.2850.03062.65log
Odds ratio, group 1 over group 20.2720.02732.7log
Number needed to treat, for one fewer participant with the outcome on Pantoprazole 40mg IV Daily and Tube Feed than on Placebo and Tube Feed.21.9from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Pantoprazole 40mg IV Daily and Tube FeedPantoprazole 40 mg IV daily and tube feed.: Patients randomized to the control group active Comparator will receive tube feed plus an Pantoprazole 40 mg IV daily.155OG000
Group 2Placebo and Tube Feed.Placebo and tube feed: Patients randomized to Placebo group placebo Comparator will receive tube feed plus an Placebo.347OG001

Outcome

Type
SECONDARY
Title
Number of Subjects With ICU-acquired C. Difficile Pseudomembranous Colitis.
Description
Time frame
Subjects will be followed until discharge from the ICU or cessation of EN and successful initiation of oral feeds up to 100 weeks.
Population

Source ClinicalTrials.gov

Trial

Title
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
NCT number
NCT01477320
Phases
NA
Conditions
Gastrointestinal Hemorrhage, Clostridium Difficile Colitis
Interventions
Pantoprazole 40 mg IV daily and tube feed., Placebo and tube feed
Lead sponsor
Mohamed Saad
Results first posted
2018-01-16

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01477320-bf0b63c4